What We Do
Encapsulated Immune-Modulatory Biologics
At TheraPYX we develop sustained-release microparticulate immune-modulatory biologics using a novel technology platform (EXStaM) for oral or mucosal delivery. The products we develop are geared toward the prevention and treatment of infection, immune-mediated inflammatory diseases, and cancer. We have a broad pipeline of products at discovery and preclinical stages.
Innovating Solutions for the Diseases of Today
Our most advanced products include NGoXIM™ for the treatment/prevention of gonorrheae and TreXTAM™ for the treatment of Crohn’s disease and Lupus.